Skip Navigation

RubrYc Therapeutics

Revolutionizing the Discovery of Antibody-Based Drugs Through Integrated Chemistry and Computation

  • CEO: Isaac Bright
  • Location: San Carlos, CA
  • Milestones: Apr 2018 - Third Point Ventures leads Series A
Go to site

RubrYc is a biotechnology solutions company using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies.